Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 5 putative open reading frame 67 (C5orf67) encodes a human protein that has not been extensively characterized with regard to its structure, function, or biological pathways. It is classified primarily as a non-coding RNA gene (lncRNA) but is also annotated as an uncharacterized protein with limited functional insights. C5orf67 lacks a defined molecular family and is not currently recognized as a therapeutic target, receptor, enzyme, transporter, or transcription factor. Some expression data and genetic association studies suggest potential, though unconfirmed, biological relevance in lipid metabolism, metabolic syndrome, and certain cancers, but concrete mechanisms and roles remain elusive. No drugs, biomarkers, or therapeutic safety information are available for C5orf67, reflecting its limited clinical and pharmacological study.
Not established; no known drugs or ligands targeting this molecule
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 5 putative open reading frame 67 (C5orf67).